Atlas Trials

Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS

Clinical trial NCT06692491 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06692491
Sponsor
Peking University Shenzhen Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rare Tumour
Start date
2025-01-01
Primary completion
2027-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.